☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Pre-P-II Programs
Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders
March 19, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.